Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 - Product Image

Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4402001
  • Report
  • 157 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Aalto Bio Reagents Ltd
  • Biocartis SA
  • Enzo Life Sciences Inc
  • Homepoint Testing
  • OncoHealth Corp
  • Sansure Biotech Inc
  • MORE
Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Human Papillomavirus (HPV) Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Human Papillomavirus (HPV) Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Human Papillomavirus (HPV) Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Human Papillomavirus (HPV) Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Human Papillomavirus (HPV) Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aalto Bio Reagents Ltd
  • Biocartis SA
  • Enzo Life Sciences Inc
  • Homepoint Testing
  • OncoHealth Corp
  • Sansure Biotech Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Human Papillomavirus (HPV) Diagnostic Tests Overview
3 Products under Development
3.1 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Territory
3.3 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Human Papillomavirus (HPV) Diagnostic Tests - Ongoing Clinical Trials
4 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Human Papillomavirus (HPV) Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development
5 Human Papillomavirus (HPV) Diagnostic Tests Companies and Product Overview
5.1 Aalto Bio Reagents Ltd Company Overview
5.1.1 Aalto Bio Reagents Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adaltis S.r.l. Company Overview
5.2.1 Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
5.3 AutoGenomics Inc Company Overview
5.3.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Beckman Coulter Inc Company Overview
5.4.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Becton Dickinson and Co Company Overview
5.5.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
5.6 Biocartis SA Company Overview
5.6.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
5.7 BioHelix Corp Company Overview
5.7.1 BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Biomagnetics Diagnostics Corporation Company Overview
5.8.1 Biomagnetics Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bioorganic Research and Services SA Company Overview
5.9.1 Bioorganic Research and Services SA Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cepheid Company Overview
5.10.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.11 China Medical Technologies Inc (Inactive) Company Overview
5.11.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.12 Co-Diagnostics HBDC, Inc. Company Overview
5.12.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Enigma Diagnostics Ltd (Inactive) Company Overview
5.13.1 Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 Enzo Life Sciences Inc Company Overview
5.14.1 Enzo Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Genera Biosystems Ltd Company Overview
5.15.1 Genera Biosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Genome Diagnostics Pvt. Ltd. Company Overview
5.16.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.17 German Cancer Research Center Company Overview
5.17.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.18 Goodgene Inc Company Overview
5.18.1 Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Great Basin Scientific Inc Company Overview
5.19.1 Great Basin Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 HEALTH BioMed Co Ltd Company Overview
5.20.1 HEALTH BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 HistoGeneX NV Company Overview
5.21.1 HistoGeneX NV Pipeline Products & Ongoing Clinical Trials Overview
5.22 Homepoint Testing Company Overview
5.22.1 Homepoint Testing Pipeline Products & Ongoing Clinical Trials Overview
5.23 IncellDx Inc Company Overview
5.23.1 IncellDx Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 KogeneBiotech Co Ltd Company Overview
5.24.1 KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 MEDITE Cancer Diagnostics Inc Company Overview
5.25.1 MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 MedNostic Technologies, LLC Company Overview
5.26.1 MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.27 Monogram Biosciences Inc Company Overview
5.27.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Novacyt SA Company Overview
5.28.1 Novacyt SA Pipeline Products & Ongoing Clinical Trials Overview
5.29 OncoHealth Corp (Inactive) Company Overview
5.29.1 OncoHealth Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.30 Pathogenica Inc Company Overview
5.30.1 Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Provista Diagnostics Inc Company Overview
5.31.1 Provista Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Qiagen NV Company Overview
5.32.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
5.33 Rheonix Inc Company Overview
5.33.1 Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Sansure Biotech Inc Company Overview
5.34.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Seattle Children's Hospital Company Overview
5.35.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.36 Sequenom Inc Company Overview
5.36.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 The Feinstein Institute for Medical Research Company Overview
5.37.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.38 TrovaGene Inc Company Overview
5.38.1 TrovaGene Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of Queensland Company Overview
5.39.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Texas at Austin Company Overview
5.40.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
5.41 ValiRx Plc Company Overview
5.41.1 ValiRx Plc Pipeline Products & Ongoing Clinical Trials Overview
5.42 Yale University Company Overview
5.42.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
6 Human Papillomavirus (HPV) Diagnostic Tests - Recent Developments
6.1 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson
6.2 Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results
6.3 Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results
6.4 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter
6.5 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017
6.6 Aug 01, 2017: Novel Genetic Test Could Help Combat the Opioid Epidemic by Identifying Patients at Risk of Addiction
6.7 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017
6.8 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results
6.9 Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements
6.10 Jun 22, 2017: HPV testing leads to earlier detection and treatment of cervical pre-cancer
6.11 Jun 06, 2017: BD Releases 2016 Sustainability Report
6.12 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors
6.13 May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results
6.14 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017
6.15 May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
6.16 May 05, 2017: ValiRx: Final Results for the Year Ended 31 December 2016
6.17 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter
6.18 May 02, 2017: QIAGEN reports results for first quarter 2017
6.19 Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
6.20 Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer
6.21 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results
6.22 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President
6.23 Apr 18, 2017: ValiRx: Change of Registered Office
6.24 Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board
6.25 Mar 28, 2017: Roche Announces Launch Of Cobas HPV On The Cobas 6800/8800 Systems For Cervical Cancer Screening In Markets Accepting The CE Mark
6.26 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management
6.27 Mar 21, 2017: Retractable Technologies Announces Litigation Updates
6.28 Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results
6.29 Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors
6.30 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
6.31 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter
6.32 Feb 01, 2017: QIAGEN Reports Results for Fourth Quarter and Full-year 2016
6.33 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017
6.34 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories
6.35 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016
6.36 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
6.37 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors
6.38 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe
6.39 Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments
6.40 Nov 07, 2016: Trovagene Announces HPV Patent Issuance by U.S. Patent and Trademark Office, Broadening Its Precision Cancer Monitoring IP Portfolio
6.41 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
6.42 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
6.43 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
6.44 Nov 02, 2016: QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017
6.45 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results
6.46 Oct 19, 2016: GeneFirst Announces CE Marking and Release of Papilloplex HR-HPV, a PCR Based Molecular Diagnostic Test for Genotyping 14 High Risk Human Papillomaviruses from Cervical and Urine Samples
6.47 Oct 03, 2016: Genera Biosystems Limited Receipt Of Data For Paptype 2,000 Specimens In US Based Screening Population
6.48 Oct 03, 2016: Genera Biosystems: 2016 Annual Report Highlights
6.49 Sep 27, 2016: ValiRx: Half Yearly Report for the Period Ended 30 June 2016
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Territory
Table 3: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Human Papillomavirus (HPV) Diagnostic Tests - Ongoing Clinical Trials
Table 6: Human Papillomavirus (HPV) Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: Aalto Bio Reagents Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AaltoCC - HPV - Product Status
Table 10: AaltoCC - HPV - Product Description
Table 11: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Table 12: MOLgen DNA HPV 16/18 Set 1 Kit - Product Status
Table 13: MOLgen DNA HPV 16/18 Set 1 Kit - Product Description
Table 14: MOLgen DNA HPV 16/18 Set 2 Kit - Product Status
Table 15: MOLgen DNA HPV 16/18 Set 2 Kit - Product Description
Table 16: MOLgen DNA HPV 26/51 Set 1 Kit - Product Status
Table 17: MOLgen DNA HPV 26/51 Set 1 Kit - Product Description
Table 18: MOLgen DNA HPV 26/51 Set 2 Kit - Product Status
Table 19: MOLgen DNA HPV 26/51 Set 2 Kit - Product Description
Table 20: MOLgen DNA HPV 26/53/66 Set 1 Kit - Product Status
Table 21: MOLgen DNA HPV 26/53/66 Set 1 Kit - Product Description
Table 22: MOLgen DNA HPV 26/53/66 Set 2 Kit - Product Status
Table 23: MOLgen DNA HPV 26/53/66 Set 2 Kit - Product Description
Table 24: MOLgen DNA HPV 31/33 Set 1 Kit - Product Status
Table 25: MOLgen DNA HPV 31/33 Set 1 Kit - Product Description
Table 26: MOLgen DNA HPV 31/33 Set 2 Kit - Product Status
Table 27: MOLgen DNA HPV 31/33 Set 2 Kit - Product Description
Table 28: MOLgen DNA HPV 35/45 Set 1 Kit - Product Status
Table 29: MOLgen DNA HPV 35/45 Set 1 Kit - Product Description
Table 30: MOLgen DNA HPV 35/45 Set 2 Kit - Product Status
Table 31: MOLgen DNA HPV 35/45 Set 2 Kit - Product Description
Table 32: MOLgen DNA HPV 44 Set 1 Kit - Product Status
Table 33: MOLgen DNA HPV 44 Set 1 Kit - Product Description
Table 34: MOLgen DNA HPV 44 Set 2 Kit - Product Status
Table 35: MOLgen DNA HPV 44 Set 2 Kit - Product Description
Table 36: MOLgen DNA HPV 6/11 Set 1 Kit - Product Status
Table 37: MOLgen DNA HPV 6/11 Set 1 Kit - Product Description
Table 38: MOLgen DNA HPV 6/11 Set 2 Kit - Product Status
Table 39: MOLgen DNA HPV 6/11 Set 2 Kit - Product Description
Table 40: MOLgen DNA HPV 6/11/44 Set 1 Kit - Product Status
Table 41: MOLgen DNA HPV 6/11/44 Set 1 Kit - Product Description
Table 42: MOLgen DNA HPV 6/11/44 Set 2 Kit - Product Status
Table 43: MOLgen DNA HPV 6/11/44 Set 2 Kit - Product Description
Table 44: MOLgen DNA HPV 66 Set 1 Kit - Product Status
Table 45: MOLgen DNA HPV 66 Set 1 Kit - Product Description
Table 46: MOLgen DNA HPV 66 Set 2 Kit - Product Status
Table 47: MOLgen DNA HPV 66 Set 2 Kit - Product Description
Table 48: MOLgen DNA HPV 68 Set 1 Kit - Product Status
Table 49: MOLgen DNA HPV 68 Set 1 Kit - Product Description
Table 50: MOLgen DNA HPV 68 Set 2 Kit - Product Status
Table 51: MOLgen DNA HPV 68 Set 2 Kit - Product Description
Table 52: MOLgen DNA HPV 68/73/82 Set 1 Kit - Product Status
Table 53: MOLgen DNA HPV 68/73/82 Set 1 Kit - Product Description
Table 54: MOLgen DNA HPV 68/73/82 Set 2 Kit - Product Status
Table 55: MOLgen DNA HPV 68/73/82 Set 2 Kit - Product Description
Table 56: MOLgen DNA HPV HCR Genotype Quantitative, Set 1 Kit - Product Status
Table 57: MOLgen DNA HPV HCR Genotype Quantitative, Set 1 Kit - Product Description
Table 58: MOLgen DNA HPV HCR Genotype Quantitative, Set 2 Kit - Product Status
Table 59: MOLgen DNA HPV HCR Genotype Quantitative, Set 2 Kit - Product Description
Table 60: MOLgen DNA HPV HCR Genotype Set 1 Kit - Product Status
Table 61: MOLgen DNA HPV HCR Genotype Set 1 Kit - Product Description
Table 62: MOLgen DNA HPV HCR Genotype Set 2 Kit - Product Status
Table 63: MOLgen DNA HPV HCR Genotype Set 2 Kit - Product Description
Table 64: MOLgen DNA HPV Screen Set 1 Kit - Product Status
Table 65: MOLgen DNA HPV Screen Set 1 Kit - Product Description
Table 66: MOLgen DNA HPV Screen Set 2 Kit - Product Status
Table 67: MOLgen DNA HPV Screen Set 2 Kit - Product Description
Table 68: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 69: INFINITI HPV Genotyping Assay - Product Status
Table 70: INFINITI HPV Genotyping Assay - Product Description
Table 71: INFINITI HPV-HR Quad Assay - Product Status
Table 72: INFINITI HPV-HR Quad Assay - Product Description
Table 73: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 74: DxN VERIS HPV Assay - Product Status
Table 75: DxN VERIS HPV Assay - Product Description
Table 76: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 77: BD Max HPV Assay - Product Status
Table 78: BD Max HPV Assay - Product Description
Table 79: BD Onclarity HPV Assay - Product Status
Table 80: BD Onclarity HPV Assay - Product Description
Table 81: BD Viper LT System - HPV - Product Status
Table 82: BD Viper LT System - HPV - Product Description
Table 83: Becton Dickinson and Co - Ongoing Clinical Trials Overview
Table 84: BD Viper LT System - HPV - Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System with Cervical Specimens
Table 85: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Idylla HPV Test - Head & Neck Cancer - Product Status
Table 87: Idylla HPV Test - Head & Neck Cancer - Product Description
Table 88: BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 89: IsoAmp Assay - HPV - Product Status
Table 90: IsoAmp Assay - HPV - Product Description
Table 91: Biomagnetics Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Diagnostic Test - HPV - Product Status
Table 93: Diagnostic Test - HPV - Product Description
Table 94: Bioorganic Research and Services SA Pipeline Products & Ongoing Clinical Trials Overview
Table 95: BNTIVD002 Assay - HPV Immune Response Monitoring - Product Status
Table 96: BNTIVD002 Assay - HPV Immune Response Monitoring - Product Description
Table 97: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 98: GeneXpert - Xpert HPV CLIA Waived - Product Status
Table 99: GeneXpert - Xpert HPV CLIA Waived - Product Description
Table 100: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 101: SPR Based DNA Chip - Sexually Transmitted Diseases - Product Status
Table 102: SPR Based DNA Chip - Sexually Transmitted Diseases - Product Description
Table 103: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 104: Co-Dx Test - Human Papillomavirus - Product Status
Table 105: Co-Dx Test - Human Papillomavirus - Product Description
Table 106: Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 107: Enigma MiniLab - HPV - Product Status
Table 108: Enigma MiniLab - HPV - Product Description
Table 109: Enzo Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Next-Generation Branched DNA Assay - HPV - Product Status
Table 111: Next-Generation Branched DNA Assay - HPV - Product Description
Table 112: Genera Biosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 113: PapType - Product Status
Table 114: PapType - Product Description
Table 115: PapType SP - Product Status
Table 116: PapType SP - Product Description
Table 117: Genera Biosystems Ltd - Ongoing Clinical Trials Overview
Table 118: PapType - Predictors 3 Study
Table 119: Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 120: Human Pappiloma Virus Real Time PCR Kit - Product Status
Table 121: Human Pappiloma Virus Real Time PCR Kit - Product Description
Table 122: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 123: HPV Genotyping Assay - Cervical Cancer - Product Status
Table 124: HPV Genotyping Assay - Cervical Cancer - Product Description
Table 125: Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 126: GG HPV DNA Genotyping Chip - Product Status
Table 127: GG HPV DNA Genotyping Chip - Product Description
Table 128: Great Basin Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 129: Diagnostic Test - Human Papilloma Virus - Product Status
Table 130: Diagnostic Test - Human Papilloma Virus - Product Description
Table 131: HEALTH BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 132: 3500Dx Genetic Analyzer - SureX HPV 25 Genotyping Assay Kit - Product Status
Table 133: 3500Dx Genetic Analyzer - SureX HPV 25 Genotyping Assay Kit - Product Description
Table 134: HistoGeneX NV Pipeline Products & Ongoing Clinical Trials Overview
Table 135: IHC Based Diagnostic Assay - HPV - Product Status
Table 136: IHC Based Diagnostic Assay - HPV - Product Description
Table 137: Homepoint Testing Pipeline Products & Ongoing Clinical Trials Overview
Table 138: HPV-Inform - Product Status
Table 139: HPV-Inform - Product Description
Table 140: IncellDx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 141: HPV OncoTect mRNA - Product Status
Table 142: HPV OncoTect mRNA - Product Description
Table 143: KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 144: SuperFast HPV Low risk 5 Multiplex Real-time PCR Kit - Product Status
Table 145: SuperFast HPV Low risk 5 Multiplex Real-time PCR Kit - Product Description
Table 146: MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 147: Diagnostic Assay - HPV - Product Status
Table 148: Diagnostic Assay - HPV - Product Description
Table 149: MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 150: MedNetic HPV Immunoassay - Product Status
Table 151: MedNetic HPV Immunoassay - Product Description
Table 152: Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 153: Human Papilloma Virus Assay - Product Status
Table 154: Human Papilloma Virus Assay - Product Description
Table 155: Novacyt SA Pipeline Products & Ongoing Clinical Trials Overview
Table 156: Genesig Kit - Human Papillomavirus 14 - Product Status
Table 157: Genesig Kit - Human Papillomavirus 14 - Product Description
Table 158: OncoHealth Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 159: HPV E6 Analyte Specific Reagents Kit - Product Status
Table 160: HPV E6 Analyte Specific Reagents Kit - Product Description
Table 161: HPV E7 Analyte Specific Reagents Kit - Product Status
Table 162: HPV E7 Analyte Specific Reagents Kit - Product Description
Table 163: Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 164: HPV Strain Genotyping Test - Product Status
Table 165: HPV Strain Genotyping Test - Product Description
Table 166: Provista Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 167: Blood-Based Diagnostic Test - Cervical Cancer - Product Status
Table 168: Blood-Based Diagnostic Test - Cervical Cancer - Product Description
Table 169: Blood-Based Diagnostic Test - Oropharyngeal Cancer - Product Status
Table 170: Blood-Based Diagnostic Test - Oropharyngeal Cancer - Product Description
Table 171: Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
Table 172: QIAscreen - HPV Assay - Product Status
Table 173: QIAscreen - HPV Assay - Product Description
Table 174: QIAsymphony RGQ - HPV Assay - Product Status
Table 175: QIAsymphony RGQ - HPV Assay - Product Description
Table 176: Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 177: Rheonix CARD HPV Assay - Product Status
Table 178: Rheonix CARD HPV Assay - Product Description
Table 179: Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 180: 15 High-risk Human Papillomavirus DNA Fluorescence Diagnostic Kit - Product Status
Table 181: 15 High-risk Human Papillomavirus DNA Fluorescence Diagnostic Kit - Product Description
Table 182: 15 High-risk Human Papillomavirus DNA Genotyping Diagnostic Kit - Product Status
Table 183: 15 High-risk Human Papillomavirus DNA Genotyping Diagnostic Kit - Product Description
Table 184: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 185: Diagnostic Test - High Risk HPV - Product Status
Table 186: Diagnostic Test - High Risk HPV - Product Description
Table 187: Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 188: AttoSense HPV Test - Product Status
Table 189: AttoSense HPV Test - Product Description
Table 190: AttoSense HPV-G Test - Product Status
Table 191: AttoSense HPV-G Test - Product Description
Table 192: AttoSense HPV-Q Test - Product Status
Table 193: AttoSense HPV-Q Test - Product Description
Table 194: The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 195: Cervical HPV Staining Kit - Product Status
Table 196: Cervical HPV Staining Kit - Product Description
Table 197: TrovaGene Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 198: HPV Diagnostic Test - Men - Product Status
Table 199: HPV Diagnostic Test - Men - Product Description
Table 200: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
Table 201: Diagnostic Test - HPV Linked Head and Neck Cancer - Product Status
Table 202: Diagnostic Test - HPV Linked Head and Neck Cancer - Product Description
Table 203: University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
Table 204: Personalized Genomic Test - Cervical Cancer - Product Status
Table 205: Personalized Genomic Test - Cervical Cancer - Product Description
Table 206: ValiRx Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 207: Diagnostic Test - HPV - Product Status
Table 208: Diagnostic Test - HPV - Product Description
Table 209: Yale University Pipeline Products & Ongoing Clinical Trials Overview
Table 210: Diagnostic Assay - Cervical Cancer - Product Status
Table 211: Diagnostic Assay - Cervical Cancer - Product Description
Table 212: Glossary

List of Figures
Figure 1: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Territory
Figure 3: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Human Papillomavirus (HPV) Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aalto Bio Reagents Ltd
  • Adaltis S.r.l.
  • AutoGenomics Inc
  • Beckman Coulter Inc
  • Becton Dickinson and Co
  • Biocartis SA
  • BioHelix Corp
  • Biomagnetics Diagnostics Corporation
  • Bioorganic Research and Services SA
  • Cepheid
  • China Medical Technologies Inc
  • Co-Diagnostics HBDC, Inc.
  • Enigma Diagnostics Ltd
  • Enzo Life Sciences Inc
  • Genera Biosystems Ltd
  • Genome Diagnostics Pvt. Ltd.
  • German Cancer Research Center
  • Goodgene Inc
  • Great Basin Scientific Inc
  • HEALTH BioMed Co Ltd
  • HistoGeneX NV
  • Homepoint Testing
  • IncellDx Inc
  • KogeneBiotech Co Ltd
  • MEDITE Cancer Diagnostics Inc
  • MedNostic Technologies, LLC
  • Monogram Biosciences Inc
  • Novacyt SA
  • OncoHealth Corp
  • Pathogenica Inc
  • Provista Diagnostics Inc
  • Qiagen NV
  • Rheonix Inc
  • Sansure Biotech Inc
  • Seattle Children's Hospital
  • Sequenom Inc
  • The Feinstein Institute for Medical Research
  • TrovaGene Inc
  • University of Queensland
  • University of Texas at Austin
  • ValiRx Plc
  • Yale University
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll